XClinical GmbH - XClinical’s analysis of 2008

Store this angel in big sizeXClinical looks aback on a acknowledged year 2008

XClinical GmbH, Munich, Germany – APR 1, 2009 – XClinical, a European bell-ringer of avant-garde software articles for eClinical trials, looks aback on a acknowledged business year 2008. Summing up, the a lot of important milestones are:

In 2008 XClinical active up for 20 trials with both new and absolute audience (once won, XClinical has not absent a individual applicant back its accumulation in 2002). In this regard, the aggregation is appreciative to accept continued its common adventures by acceptable new audience (CROs, DMOs and sponsors) in USA, Japan, Germany, Czech Republic, Belgium, Switzerland and France. “Internationality is one of the capital locations of our business action as able-bodied as our abstraction of TechTransfer”, said Dr. Claus Lindenau, Head of Business Development at XClinical. “Our ambition is to body up an all-embracing arrangement of certified partners. Having absitively to conduct a TechTransfer our audience are able to set up and administer their studies on their own. We’re contented that a lot of of our audience absitively to use our articles this way.” Also MARVIN’s Double Data Entry functionality, which was alien end 2007, admiring abundant new customers.
XClinical’s Consulting Business for all-embracing biologic companies was aswell continued during the endure year.
The business action led to success. XClinical accomplished added than 20% advance in 2008; something which can’t be taken for accepted in difficult bread-and-butter times. Looking at its bounded administration – XClinical is breath in the EDC markets of USA, Europe and Asia – it is acutely apparent that the aggregation continued its all-around presence.

This is in no baby allotment due to XClinical’s common accord at the a lot of important all-embracing Data Management contest in USA, Europe, Japan and China during 2008. “From our point of appearance on the one duke those contest are ideal platforms to get in blow with the accordant acquaintance bodies from the biologic and biotechnological industry but on the added hand, by exchanging experiences, accredit us to enhance our competencies which at the end of the day account our customers.” declared Dr. Lindenau. In accession XClinical has been arrive as able for EDC and CDM at all-embracing conferences of CDISC and DIA.
For 2009 XClinical is planning to carbon endure year’s success and to augment its all-embracing network. New artefact developments and the connected appearance at all-embracing contest will bright the way for the ambition achievement.

About XClinical
XClinical GmbH (www.xclinical.com), an avant-garde EDC-CDM arrangement bell-ringer based in Munich, Paris and Boston, USA, provides solutions for the cyberbanking conduct of all types of analytic trials, post-marketing studies and registries.
XClinical develops and markets MARVIN, a CDISC ODM certified online belvedere for Electronic Data Capture (EDC), Clinical Data Management (CDM) and Clinical Trial Management (CTM). Till today, MARVIN was acclimated to aggregate and action abstracts of added than 50,000 patients in 70+ studies.

XClinical GmbH
Siegfriedstraße 8
80803 Munich
Germany

Katharina Lang
Phone: +49 (0)89 / 45 22 77 – 52 20
Email: press@xclinical.com